High OPCAB Surgical Volume Improves Midterm Event-Free Survival
The aim of this study was to evaluate the midterm results of the initial phase of off-pump coronary artery bypass (OPCAB) surgery adoption in a single surgical unit, assessing the impact of procedural volume.
Methods: Study participants were 312 patients who underwent OPCAB during the period between August 2000 and January 2005 at S. Croce Hospital. Of these patients, 126 patients with an indication selected for comorbidities or 1-vessel disease underwent OPCAB performed by 4 low-volume surgeons, and 186 unselected patients underwent OPCAB performed by a single high-volume surgeon.
Results: OPCAB performed by low-volume surgeons was associated with less complete revascularization and less arterial conduit use. Early result analysis showed a low rate of in-hospital or 30-day adverse events. The 5-year survival was 0.88 (0.02 SE). OPCAB performance by a high-volume surgeon and complete revascularization were shown have a protective effect for midterm major adverse cardiac events (respectively, hazard ratio = 0.28, 95% confidence interval 0.11-0.74 and hazard ratio = 0.33, 95% confidence interval 0.15-0.73).
Conclusion: Our study on the initial phase of OPCAB adoption suggests a benefit on midterm outcome from surgery performed by a high-volume surgeon.
Al-Ruzzeh S, Ambler G, Asimakopulos G, et al. 2003. Off-pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a United Kingdom multi-center comparative analysis of early clinical outcome. Circulation 108:III1-8.nAl-Ruzzeh S, George S, Bustami M, et al. 2006. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive and quality of life outcomes: randomized controlled trial. BMJ 332:1365.nAngelini GD, Taylor FC, Reeves BC, Ascione R. 2002. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomized controlled trials. Lancet 359:1194-9.nAsimakopulos G, Karagounis AP, Valencia O, Rose D, Niranjan G, Chandrasekaran V. 2006. How safe is it to train residents to perform off-pump coronary artery bypass surgery? Ann Thorac Surg 81:568-72.nBraunwald E, Antman EM, Beasley JW, et al. 2000. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 36:970-1062.nBrevetti G, Schiano V, Verdoliva S, et al. 2006. Peripheral arterial disease and cardiovascular risk in Italy: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. J Cardiovasc Med 7:608-13.nBypass Angioplasty Revascularization Investigation (BARI) investigators. 1996. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217-25.nCaputo M, Reeves BC, Rogers CA, Ascione R, Angelini GD. 2004. Monitoring the performance of residents during training on off-pump coronary surgery. J Thorac Cardiovasc Surg 128:907-15.nCooper WA, O'Brien SM, Thourani VH, et al. 2006. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113:1063-70.nCox DR. 1982. Regression models and life-tables. J Royal Stat Soc 34:187-220.nGlance LG, Dick AW, Osler TM, Mulcamel DB. 2005. The relation between surgeon volume and outcome following off-pump vs on-pump coronary artery bypass graft surgery. Chest 128:829-37.nHannan EL, Wu C, Smith CR, et al. 2007. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation 116:1145-52.nHillis GS, Croal BL, Buchan KG, et al. 2006. Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. Circulation 113:1056-62.nKilo J, Harald B, Czerny M, et al. 2001. Target vessel revascularization without cardiopulmonary bypass in elderly high-risk patients. Ann Thorac Surg 71:537-42.nKubal C, Srinivasan AK, Grayson AD, Fabri BM, Chalmers JA. 2005. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery. Ann Thorac Surg 79:1570-6.nLeavitt BJ, Ross CS, Spence B, et al. 2006. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery. Circulation 114:I430-4.nLeavitt BJ, Sheppard L, Maloney C, et al. 2004. Effects of diabetes and associated conditions on long term survival after coronary artery bypass surgery. Circulation 110:II41-4.nMurphy GJ, Rogers CA, Caputo M, Angelini GD. 2005. Acquiring proficiency in off-pump surgery: traversing the learning curve, reproducibility, and quality control. Ann Thorac Surg 80:1965-70.nMyles PS, Daly DJ, Djaiani G, Lee A, Cheng DC. 2003. A systematic review of the safety and effectiveness of fast-track cardiac anaesthesia. Anesthesiology 99:982-7.nNashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. 1999. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13.nPlomondon ME, Casebeer AW, Schooley L, et al. 2006. Exploring the volume-outcome relationship for off-pump coronary artery bypass procedures. Ann Thorac Surg 81:547-53.nRogers CA, Reeves BC, Caputo M, Ganesh JS, Bonser RS, Angelini GD. 2004. Control chart methods for monitoring cardiac surgical performance and their interpretation. J Thorac Cardiovasc Surg 128:811-9.nSergeant P, de Worm E, Meyers B, Wouters P. 2001. The challenge of departmental quality control in the reengineering towards off-pump coronary artery byapass grafting. Eur J Cardiothorac Surg 20:538-43.nSerruys PW, Unger F, Sousa JE, et al. 2001. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivassel disease. N Engl J Med 344:1117-24.nVander Salm TJ, Kip KE, Jones RH, et al. 2002. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 39:565-72.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).